Ellis David A F, Segall Lorne
Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
Facial Plast Surg Clin North Am. 2007 May;15(2):239-46, vii. doi: 10.1016/j.fsc.2007.02.006.
The number of commercially available injectable soft tissue fillers has increased dramatically worldwide over the past decade. In the United States, a variety of temporary non-collagen-based fillers have been approved. However, no permanent soft tissue injectable fillers are currently approved by the US Food and Drug Administration. This article discusses some of the more popular soft tissue fillers, such as Restylane Fine Line, Restylane SQ, Perlane, Artecoll, Dermalive, Dermadeep, Bioalcamid, Bioplastique, Evolution, Outline, Argiform, and Aquamid, which are all available outside of the United States.
在过去十年间，全球范围内市售的可注射软组织填充剂数量急剧增加。在美国，多种基于非胶原蛋白的临时填充剂已获批准。然而，目前美国食品药品监督管理局尚未批准任何永久性软组织可注射填充剂。本文讨论了一些较受欢迎的软组织填充剂，如瑞蓝细纹填充剂、瑞蓝SQ填充剂、乔雅登填充剂、爱贝芙、德美莱卡、德美丝、生物卡梅德、生物塑型、伊婉、轮廓、阿吉弗以及奥美定，这些产品在美国境外均可获得。
